Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1996-01-11
1998-05-12
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
546124, A61K 5104
Patent
active
057500894
ABSTRACT:
An iodinated neuroprobe is provided for mapping monoamine reuptake sites. The iodinated neuroprobe is of the formula: ##STR1## wherein R= ##STR2## wherein n=2-8; R'=C.sub.w H.sub.2w+1 wherein w=0-6 and C includes an isotope of carbon; and
X=an isotope of Cl, an isotope of Br, an isotope of F, an isotope of I, or Sn(R".sub.1 R".sub.2 R".sub.3), wherein
REFERENCES:
patent: 3813404 (1974-05-01), Clarke et al.
patent: 4794178 (1988-12-01), Coenen et al.
patent: 4942231 (1990-07-01), Mertens
patent: 5098996 (1992-03-01), Jacobson et al.
patent: 5104638 (1992-04-01), Nosco
patent: 5128118 (1992-07-01), Carroll et al.
patent: 5186921 (1993-02-01), Kung et al.
patent: 5200169 (1993-04-01), Wilbur et al.
patent: 5369113 (1994-11-01), Moldt et al.
patent: 5380848 (1995-01-01), Kuhar et al.
patent: 5413779 (1995-05-01), Kuhar et al.
patent: 5439666 (1995-08-01), Neumeyer et al.
patent: 5493026 (1996-02-01), Elmaleh et al.
patent: 5506359 (1996-04-01), Madras et al.
American College of Neuropsychopharmacology "Neurochemical and Behavioral Effects of Potency Cocaine Analogs", Abstract of 29th Annual Meeting, p. 207 (1990) by J.W. Boja. Transporters", Eur. Jour. Pharm., vol. 194, 1991, pp. 133-134.
Boja, J.W., et al., "New Potent Cocaine Analogs: Ligand Binding and Transport Studies in Rat Striatum", Eur. Journal of Pharm., vol. 184, 1990, pp. 329-332.
Clarke, R.L., et al., Compounds Affecting the Central Nervous System, 4.3.beta.-Phenyltropane-2-carboxylic Esters and Analogs, Journal of Med. Chem. vol. 16, No. 11, 1973, pp. 1260-1267.
Dagani, R., "Cocaine analog for Parkinsonism studies", Chemical & Engineering News, Oct. 1991, p. 26.
Innis, R., et al., Single Photon Emission Computed Tomography Imaging of Journal of Pharm., vol. 200, 1991, pp. 369-370. H!2.beta.-Carbomethoxy-3.beta.-(4-fluorophenyl)tropane, Molecular Pharmacology 36:pp. 518-525, 1989.
"Membrane Receptors", Poster 342, The FASEB Journal 4:A325, Feb. 26, 1990.
Milius, R.A., et al., Synthesis and Receptor binding of N-Substituted Tropane Derivatives. High-Affinity Ligands for the Cocaine Receptor, J. Med. Chem., vol. 34, 1991, pp. 1728-1731. I!-2.beta.-Carbomethoxy-3.beta.-(4-iodophenyl)tropane: High-Affinity SPECT Radiotracer of Monoamine Reuptake Site in Brain", J. Med. Chem., vol. 34, 1991, #10, pp. 3144-3146.
Neumeyer, J.L., et al., "N-Substituted Analogs of 2.beta.-Carbomethoxy-3.beta.-(4'-iodophenyl)tropane (.beta.-CIT) with Selective Affinity to Dopamine or Serotonin Transporters in Rat Forebrain", J. Med. Chem., vol. 39, 1996, pp. 543-548.
Seitz, D.E., et al., "Tritiodestannylation Synthesis of a Specifically pp. 281-286.
Milius Richard A.
Neumeyer John L.
Tamagnan Gilles
Wang Shaoyin
Hartley Michael G.
Hollinden Gary E.
Neuro Imaging Technologies, LLC
LandOfFree
Halogenated neuroprobe for mapping monoamine reuptake sites does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Halogenated neuroprobe for mapping monoamine reuptake sites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halogenated neuroprobe for mapping monoamine reuptake sites will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-976733